November National provider Data Summary

Updated: Nov 14, 2019

November National Provider Data Summary

  • At the end of November 2018, 87.3% of patients waiting to start treatment (incomplete pathways) were waiting up to 18 weeks, thus not meeting the 92% standard.

  • The number of RTT patients waiting to start treatment at the end of November 2018 was 4.2 million patients. Of those, 2,432 patients were waiting more than 52 weeks.

  • For patients waiting to start treatment at the end of November 2018, the median waiting time was 6.9 weeks. The 92nd percentile waiting time was 22.0 weeks.

  • During November 2018, 321,151 RTT patients started admitted treatment and 1,160,655 started non-admitted treatment (completed pathways).

There are currently 4 Trust’s that are not reporting RTT data:

  • Gloucestershire Hospitals NHS Foundation Trust (RTE)

  • Mid Essex Hospital Services NHS Trust (RQ8)

  • St George's University Hospitals NHS Foundation Trust (RJ7)

  • St Helen's and Knowsley Teaching Hospitals NHS Trust (RBN)

RTT Performance

As the below heatmap and graph shows, there has been a substantial deterioration in RTT performance nationally when compared to November 2017. 




Waiting List Size

As the below graph demonstrates, from March 2018 to November 2018 the total waiting list size increased from 3,843,182 to 4,150,685, an increase of 307,503 (8.00%).


Below is a table showing each reporting Trusts variance in waiting list size from March 2018 to November 2018, sorted by percentage variance (please click to view the whole table).


52 Week Waiters

The below heatmap shows how the number of 52-week waiters has changed nationally, with some areas such as the South West suffering a significant increase, but other areas such as the East Midlands managing to reduce their number of 52-week waiters.


Below is a table showing each reporting Trust’s variance in 52-week waiters from March 2018 to November 2018, sorted by percentage variance (please click to view the whole table).


Changes to the Individual Specialties

In regard to the waiting list size of the individual specialties:


  • Geriatric Medicine saw the highest percentage decrease, going from 20,889 to 20,023 a decrease of 866 pathways (4.14%), however Dermatology saw the highest decrease in pathways, going from 223,385 to 215,948 a decrease of 7,437 pathways (3.32%). 

  • Trauma & Orthopaedics also saw a high decrease in the waiting list size going from 505,427 to 500,427, a decrease of 5,000 pathways (0.98%).

  • Gynaecology and Neurology both saw a high increase in the waiting list size. Gynaecology going from 252,724 to 254,198, an increase of 1,474 pathways (0.58%) and Neurology going from 127,883 to 128,749, an increase of 866 pathways (0.67%). 

  • Urology, as a single specialty saw the largest percentage increase as well as the largest increase of pathways, going from 228,765 to 231,845, an increase of 3,080 pathways (1.34%).



Summary

  • At the end of November 2018, 87.3% of patients waiting to start treatment (incomplete pathways) were waiting up to 18 weeks, thus not meeting the 92% standard.

  • The number of RTT patients waiting to start treatment at the end of November 2018 was 4.2 million patients. Of those, 2,432 patients were waiting more than 52 weeks.

  • For patients waiting to start treatment at the end of November 2018, the median waiting time was 6.9 weeks. The 92nd percentile waiting time was 22.0 weeks.

  • During November 2018, 321,151 RTT patients started admitted treatment and 1,160,655 started non-admitted treatment (completed pathways).

The challenge continues to reduce the size of the waiting lists and patients waiting over 52 weeks. It appears some specialties are managing to reduce the size of their lists and wonder whether this is through additional activity or cleansing of the waiting lists? 

Contact Us

Beech House 10-12 Temple End, High Wycombe, Bucks HP13 5DR

Tel. 020 3727 4180

© 2020 Insource Select Ltd, trading as Source Group

Terms and Conditions I Privacy

Read Our GDPR compliance policy

  • Source Group
  • Source Group
  • Source Group